nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.12	0.131	CbGbCtD
Pitavastatin—ABCC2—Sulfasalazine—ankylosing spondylitis	0.106	0.115	CbGbCtD
Pitavastatin—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0954	0.104	CbGbCtD
Pitavastatin—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0827	0.0902	CbGbCtD
Pitavastatin—ABCC2—Dexamethasone—ankylosing spondylitis	0.0527	0.0574	CbGbCtD
Pitavastatin—ALB—Prednisone—ankylosing spondylitis	0.0526	0.0573	CbGbCtD
Pitavastatin—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0482	0.0525	CbGbCtD
Pitavastatin—ABCG2—Dexamethasone—ankylosing spondylitis	0.0476	0.0519	CbGbCtD
Pitavastatin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0454	0.0495	CbGbCtD
Pitavastatin—ABCC2—Methotrexate—ankylosing spondylitis	0.0423	0.0461	CbGbCtD
Pitavastatin—ABCG2—Methotrexate—ankylosing spondylitis	0.0383	0.0417	CbGbCtD
Pitavastatin—ABCB1—Betamethasone—ankylosing spondylitis	0.0295	0.0322	CbGbCtD
Pitavastatin—ABCB1—Prednisolone—ankylosing spondylitis	0.0291	0.0317	CbGbCtD
Pitavastatin—ABCB1—Prednisone—ankylosing spondylitis	0.0275	0.03	CbGbCtD
Pitavastatin—ALB—Methotrexate—ankylosing spondylitis	0.0264	0.0288	CbGbCtD
Pitavastatin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0254	0.0277	CbGbCtD
Pitavastatin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0177	0.0193	CbGbCtD
Pitavastatin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0172	0.0187	CbGbCtD
Pitavastatin—ABCB1—Methotrexate—ankylosing spondylitis	0.0138	0.015	CbGbCtD
Pitavastatin—Cognitive impairment—Dexamethasone—ankylosing spondylitis	0.00375	0.0453	CcSEcCtD
Pitavastatin—Cognitive impairment—Betamethasone—ankylosing spondylitis	0.00375	0.0453	CcSEcCtD
Pitavastatin—Cognitive impairment—Prednisone—ankylosing spondylitis	0.00327	0.0395	CcSEcCtD
Pitavastatin—Memory loss—Prednisone—ankylosing spondylitis	0.0029	0.035	CcSEcCtD
Pitavastatin—Cognitive impairment—Methotrexate—ankylosing spondylitis	0.00273	0.033	CcSEcCtD
Pitavastatin—Cognitive disorder—Methylprednisolone—ankylosing spondylitis	0.00249	0.0301	CcSEcCtD
Pitavastatin—Cognitive disorder—Betamethasone—ankylosing spondylitis	0.00226	0.0273	CcSEcCtD
Pitavastatin—Cognitive disorder—Dexamethasone—ankylosing spondylitis	0.00226	0.0273	CcSEcCtD
Pitavastatin—Cognitive disorder—Prednisone—ankylosing spondylitis	0.00197	0.0238	CcSEcCtD
Pitavastatin—Myopathy—Prednisolone—ankylosing spondylitis	0.00167	0.0202	CcSEcCtD
Pitavastatin—Cognitive disorder—Methotrexate—ankylosing spondylitis	0.00165	0.0199	CcSEcCtD
Pitavastatin—Myopathy—Triamcinolone—ankylosing spondylitis	0.00154	0.0186	CcSEcCtD
Pitavastatin—Myopathy—Methylprednisolone—ankylosing spondylitis	0.00154	0.0185	CcSEcCtD
Pitavastatin—Myopathy—Betamethasone—ankylosing spondylitis	0.0014	0.0169	CcSEcCtD
Pitavastatin—Myopathy—Dexamethasone—ankylosing spondylitis	0.0014	0.0169	CcSEcCtD
Pitavastatin—Myopathy—Prednisone—ankylosing spondylitis	0.00122	0.0147	CcSEcCtD
Pitavastatin—Memory impairment—Prednisone—ankylosing spondylitis	0.00109	0.0131	CcSEcCtD
Pitavastatin—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.00101	0.0122	CcSEcCtD
Pitavastatin—Amnesia—Methylprednisolone—ankylosing spondylitis	0.000832	0.01	CcSEcCtD
Pitavastatin—Influenza—Triamcinolone—ankylosing spondylitis	0.000677	0.00818	CcSEcCtD
Pitavastatin—Amnesia—Prednisone—ankylosing spondylitis	0.000659	0.00796	CcSEcCtD
Pitavastatin—Hepatic failure—Methotrexate—ankylosing spondylitis	0.000576	0.00695	CcSEcCtD
Pitavastatin—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00056	0.00677	CcSEcCtD
Pitavastatin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000493	0.00595	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000476	0.00575	CcSEcCtD
Pitavastatin—Malaise—Prednisolone—ankylosing spondylitis	0.000463	0.00559	CcSEcCtD
Pitavastatin—Back pain—Triamcinolone—ankylosing spondylitis	0.000456	0.00551	CcSEcCtD
Pitavastatin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000438	0.00529	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000437	0.00527	CcSEcCtD
Pitavastatin—Discomfort—Prednisolone—ankylosing spondylitis	0.000432	0.00521	CcSEcCtD
Pitavastatin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000429	0.00518	CcSEcCtD
Pitavastatin—Malaise—Triamcinolone—ankylosing spondylitis	0.000425	0.00514	CcSEcCtD
Pitavastatin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000424	0.00513	CcSEcCtD
Pitavastatin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000412	0.00497	CcSEcCtD
Pitavastatin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000402	0.00485	CcSEcCtD
Pitavastatin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000401	0.00484	CcSEcCtD
Pitavastatin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000401	0.00484	CcSEcCtD
Pitavastatin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000397	0.0048	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000397	0.0048	CcSEcCtD
Pitavastatin—Discomfort—Triamcinolone—ankylosing spondylitis	0.000397	0.00479	CcSEcCtD
Pitavastatin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000396	0.00478	CcSEcCtD
Pitavastatin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000387	0.00468	CcSEcCtD
Pitavastatin—Malaise—Betamethasone—ankylosing spondylitis	0.000386	0.00466	CcSEcCtD
Pitavastatin—Malaise—Dexamethasone—ankylosing spondylitis	0.000386	0.00466	CcSEcCtD
Pitavastatin—Insomnia—Prednisolone—ankylosing spondylitis	0.000379	0.00457	CcSEcCtD
Pitavastatin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000364	0.0044	CcSEcCtD
Pitavastatin—Myalgia—Betamethasone—ankylosing spondylitis	0.000364	0.0044	CcSEcCtD
Pitavastatin—Discomfort—Betamethasone—ankylosing spondylitis	0.00036	0.00435	CcSEcCtD
Pitavastatin—Discomfort—Dexamethasone—ankylosing spondylitis	0.00036	0.00435	CcSEcCtD
Pitavastatin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000358	0.00432	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000351	0.00424	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00035	0.00423	CcSEcCtD
Pitavastatin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000348	0.00421	CcSEcCtD
Pitavastatin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000347	0.0042	CcSEcCtD
Pitavastatin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000346	0.00418	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000345	0.00417	CcSEcCtD
Pitavastatin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000339	0.00409	CcSEcCtD
Pitavastatin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000338	0.00408	CcSEcCtD
Pitavastatin—Malaise—Prednisone—ankylosing spondylitis	0.000336	0.00406	CcSEcCtD
Pitavastatin—Urticaria—Prednisolone—ankylosing spondylitis	0.000333	0.00402	CcSEcCtD
Pitavastatin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000332	0.00401	CcSEcCtD
Pitavastatin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000331	0.004	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000318	0.00384	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000318	0.00384	CcSEcCtD
Pitavastatin—Arthralgia—Prednisone—ankylosing spondylitis	0.000317	0.00383	CcSEcCtD
Pitavastatin—Myalgia—Prednisone—ankylosing spondylitis	0.000317	0.00383	CcSEcCtD
Pitavastatin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000317	0.00383	CcSEcCtD
Pitavastatin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000317	0.00382	CcSEcCtD
Pitavastatin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000316	0.00382	CcSEcCtD
Pitavastatin—Insomnia—Betamethasone—ankylosing spondylitis	0.000316	0.00382	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000314	0.00379	CcSEcCtD
Pitavastatin—Discomfort—Prednisone—ankylosing spondylitis	0.000314	0.00379	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000308	0.00372	CcSEcCtD
Pitavastatin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000308	0.00371	CcSEcCtD
Pitavastatin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000308	0.00371	CcSEcCtD
Pitavastatin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000306	0.00369	CcSEcCtD
Pitavastatin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000305	0.00369	CcSEcCtD
Pitavastatin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000304	0.00367	CcSEcCtD
Pitavastatin—Back pain—Methotrexate—ankylosing spondylitis	0.000301	0.00364	CcSEcCtD
Pitavastatin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000301	0.00364	CcSEcCtD
Pitavastatin—Fatigue—Betamethasone—ankylosing spondylitis	0.000301	0.00364	CcSEcCtD
Pitavastatin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000289	0.00349	CcSEcCtD
Pitavastatin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000288	0.00348	CcSEcCtD
Pitavastatin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000288	0.00348	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000286	0.00345	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000286	0.00345	CcSEcCtD
Pitavastatin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000284	0.00343	CcSEcCtD
Pitavastatin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000283	0.00342	CcSEcCtD
Pitavastatin—Malaise—Methotrexate—ankylosing spondylitis	0.000281	0.00339	CcSEcCtD
Pitavastatin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000278	0.00335	CcSEcCtD
Pitavastatin—Urticaria—Betamethasone—ankylosing spondylitis	0.000278	0.00335	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000277	0.00335	CcSEcCtD
Pitavastatin—Dizziness—Prednisolone—ankylosing spondylitis	0.000277	0.00334	CcSEcCtD
Pitavastatin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000276	0.00334	CcSEcCtD
Pitavastatin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000276	0.00333	CcSEcCtD
Pitavastatin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000276	0.00333	CcSEcCtD
Pitavastatin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000276	0.00333	CcSEcCtD
Pitavastatin—Insomnia—Prednisone—ankylosing spondylitis	0.000275	0.00332	CcSEcCtD
Pitavastatin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000272	0.00329	CcSEcCtD
Pitavastatin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000272	0.00328	CcSEcCtD
Pitavastatin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000268	0.00323	CcSEcCtD
Pitavastatin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000265	0.0032	CcSEcCtD
Pitavastatin—Myalgia—Methotrexate—ankylosing spondylitis	0.000265	0.0032	CcSEcCtD
Pitavastatin—Rash—Prednisolone—ankylosing spondylitis	0.000264	0.00319	CcSEcCtD
Pitavastatin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000264	0.00318	CcSEcCtD
Pitavastatin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000263	0.00317	CcSEcCtD
Pitavastatin—Fatigue—Prednisone—ankylosing spondylitis	0.000262	0.00317	CcSEcCtD
Pitavastatin—Headache—Prednisolone—ankylosing spondylitis	0.000262	0.00317	CcSEcCtD
Pitavastatin—Discomfort—Methotrexate—ankylosing spondylitis	0.000262	0.00316	CcSEcCtD
Pitavastatin—Constipation—Prednisone—ankylosing spondylitis	0.00026	0.00314	CcSEcCtD
Pitavastatin—Confusional state—Methotrexate—ankylosing spondylitis	0.000256	0.0031	CcSEcCtD
Pitavastatin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000255	0.00307	CcSEcCtD
Pitavastatin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000254	0.00307	CcSEcCtD
Pitavastatin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000251	0.00303	CcSEcCtD
Pitavastatin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000251	0.00303	CcSEcCtD
Pitavastatin—Asthenia—Betamethasone—ankylosing spondylitis	0.000251	0.00303	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000249	0.003	CcSEcCtD
Pitavastatin—Nausea—Prednisolone—ankylosing spondylitis	0.000249	0.003	CcSEcCtD
Pitavastatin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000247	0.00298	CcSEcCtD
Pitavastatin—Pruritus—Betamethasone—ankylosing spondylitis	0.000247	0.00298	CcSEcCtD
Pitavastatin—Rash—Triamcinolone—ankylosing spondylitis	0.000243	0.00293	CcSEcCtD
Pitavastatin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000243	0.00293	CcSEcCtD
Pitavastatin—Rash—Methylprednisolone—ankylosing spondylitis	0.000242	0.00292	CcSEcCtD
Pitavastatin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000242	0.00292	CcSEcCtD
Pitavastatin—Urticaria—Prednisone—ankylosing spondylitis	0.000242	0.00292	CcSEcCtD
Pitavastatin—Headache—Triamcinolone—ankylosing spondylitis	0.000241	0.00291	CcSEcCtD
Pitavastatin—Headache—Methylprednisolone—ankylosing spondylitis	0.000241	0.00291	CcSEcCtD
Pitavastatin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000241	0.0029	CcSEcCtD
Pitavastatin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000239	0.00289	CcSEcCtD
Pitavastatin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000239	0.00289	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000232	0.0028	CcSEcCtD
Pitavastatin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000231	0.00279	CcSEcCtD
Pitavastatin—Dizziness—Betamethasone—ankylosing spondylitis	0.000231	0.00279	CcSEcCtD
Pitavastatin—Insomnia—Methotrexate—ankylosing spondylitis	0.00023	0.00278	CcSEcCtD
Pitavastatin—Nausea—Triamcinolone—ankylosing spondylitis	0.000229	0.00276	CcSEcCtD
Pitavastatin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000228	0.00276	CcSEcCtD
Pitavastatin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000224	0.00271	CcSEcCtD
Pitavastatin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000224	0.0027	CcSEcCtD
Pitavastatin—Rash—Dexamethasone—ankylosing spondylitis	0.00022	0.00266	CcSEcCtD
Pitavastatin—Rash—Betamethasone—ankylosing spondylitis	0.00022	0.00266	CcSEcCtD
Pitavastatin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00022	0.00266	CcSEcCtD
Pitavastatin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00022	0.00266	CcSEcCtD
Pitavastatin—Fatigue—Methotrexate—ankylosing spondylitis	0.000219	0.00265	CcSEcCtD
Pitavastatin—Headache—Dexamethasone—ankylosing spondylitis	0.000219	0.00264	CcSEcCtD
Pitavastatin—Headache—Betamethasone—ankylosing spondylitis	0.000219	0.00264	CcSEcCtD
Pitavastatin—Asthenia—Prednisone—ankylosing spondylitis	0.000218	0.00264	CcSEcCtD
Pitavastatin—Pruritus—Prednisone—ankylosing spondylitis	0.000215	0.0026	CcSEcCtD
Pitavastatin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00021	0.00253	CcSEcCtD
Pitavastatin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000208	0.00251	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000208	0.00251	CcSEcCtD
Pitavastatin—Nausea—Betamethasone—ankylosing spondylitis	0.000208	0.00251	CcSEcCtD
Pitavastatin—Nausea—Dexamethasone—ankylosing spondylitis	0.000208	0.00251	CcSEcCtD
Pitavastatin—Urticaria—Methotrexate—ankylosing spondylitis	0.000202	0.00244	CcSEcCtD
Pitavastatin—Dizziness—Prednisone—ankylosing spondylitis	0.000201	0.00243	CcSEcCtD
Pitavastatin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000201	0.00243	CcSEcCtD
Pitavastatin—Rash—Prednisone—ankylosing spondylitis	0.000192	0.00232	CcSEcCtD
Pitavastatin—Dermatitis—Prednisone—ankylosing spondylitis	0.000192	0.00231	CcSEcCtD
Pitavastatin—Headache—Prednisone—ankylosing spondylitis	0.000191	0.0023	CcSEcCtD
Pitavastatin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000187	0.00226	CcSEcCtD
Pitavastatin—Asthenia—Methotrexate—ankylosing spondylitis	0.000182	0.0022	CcSEcCtD
Pitavastatin—Nausea—Prednisone—ankylosing spondylitis	0.000181	0.00218	CcSEcCtD
Pitavastatin—Pruritus—Methotrexate—ankylosing spondylitis	0.00018	0.00217	CcSEcCtD
Pitavastatin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000174	0.0021	CcSEcCtD
Pitavastatin—Dizziness—Methotrexate—ankylosing spondylitis	0.000168	0.00203	CcSEcCtD
Pitavastatin—Rash—Methotrexate—ankylosing spondylitis	0.00016	0.00194	CcSEcCtD
Pitavastatin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00016	0.00193	CcSEcCtD
Pitavastatin—Headache—Methotrexate—ankylosing spondylitis	0.000159	0.00192	CcSEcCtD
Pitavastatin—Nausea—Methotrexate—ankylosing spondylitis	0.000151	0.00182	CcSEcCtD
